1. |
Prophylaxis after occupational exposure to HIV |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1147KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Maternal immunisation is a must |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 3-4
Gill Higgins,
Preview
|
PDF (2085KB)
|
|
摘要:
The success of maternal immunisation has been demonstrated by the use of tetanus vaccination programmes in developing countries. Many more diseases that can occur during the first few weeks of life could be prevented by this strategy. The science to support this idea is available, but there is some way to go before it is put into practice. Research is underway with a number of vaccines, including one that protects against group B streptococcus (GBS) infections. The current status of development of this vaccine was described at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [New Orleans, US; September 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
Considering varicella vaccine in pregnancy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1077KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1020KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Patient risks guide duration of anticoagulant therapy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1059KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
Combined radio- and antineoplastic therapy justified for colorectal cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1047KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1053KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
High hopes for pramlintide as treatment for diabetes mellitus |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 9-10
Gill Higgins,
Preview
|
PDF (2160KB)
|
|
摘要:
Does the synthetic human amylin analogue pramlintide have blockbuster potential as a treatment for diabetes mellitus? Johnson & Johnson certainly appears confident about the drug's potential, as demonstrated by the company's continuing financial support of clinical trials with this agent. Indeed, if approval is granted for pramlintide, the drug will be the first new agent for treating insulin-dependent diabetes mellitus (IDDM) since the discovery of insulin 75 years ago. Currently, pramlintide is in phase III development with the US-based company Amylin Pharmaceuticals. This week,Inpharma® looks at the drug's efficacy in phase II trials, and its possible therapeutic niche as an adjunct to insulin therapy in the treatment of diabetes mellitus.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
Blocking coreceptor may halt HIV progression |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1104KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
Depot medroxyprogesterone effective in endometriosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1056,
1996,
Page 11-11
&NA;,
Preview
|
PDF (970KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|